Trevi Therapeutics (TRVI) PT Raised to $21 at Leerink Partners
Tweet
Share
E-mailGet Alerts TRVI Hot Sheet
Price: $18.31 -0.81%
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Leerink Partners analyst Roanna Ruiz raised the price target on Trevi Therapeutics (NASDAQ: TRVI) to $21.00 (from $16.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) gains nearly 6% as traders follow the money
- Benchmark Reiterates Buy Rating on Ooma (OOMA)
- Global debt issuance falls 16% in latest week, Goldman says
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
